JP2022542443A5 - - Google Patents
Info
- Publication number
- JP2022542443A5 JP2022542443A5 JP2022506455A JP2022506455A JP2022542443A5 JP 2022542443 A5 JP2022542443 A5 JP 2022542443A5 JP 2022506455 A JP2022506455 A JP 2022506455A JP 2022506455 A JP2022506455 A JP 2022506455A JP 2022542443 A5 JP2022542443 A5 JP 2022542443A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- seq
- bcma
- amino acid
- antigen receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382673.2 | 2019-08-02 | ||
| EP19382673 | 2019-08-02 | ||
| PCT/EP2020/071831 WO2021023721A1 (en) | 2019-08-02 | 2020-08-03 | Car t-cells against bcma for the treatment of multiple myeloma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022542443A JP2022542443A (ja) | 2022-10-03 |
| JP2022542443A5 true JP2022542443A5 (cg-RX-API-DMAC7.html) | 2023-08-14 |
| JP7729561B2 JP7729561B2 (ja) | 2025-08-26 |
Family
ID=67658496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506455A Active JP7729561B2 (ja) | 2019-08-02 | 2020-08-03 | 多発性骨髄腫治療用の抗bcma car t細胞 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US12509525B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4272837A3 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7729561B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020325690A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3148930A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK4007777T5 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2971033T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI4007777T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20240037T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE064890T2 (cg-RX-API-DMAC7.html) |
| LT (1) | LT4007777T (cg-RX-API-DMAC7.html) |
| PL (1) | PL4007777T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT4007777T (cg-RX-API-DMAC7.html) |
| RS (1) | RS65094B1 (cg-RX-API-DMAC7.html) |
| SI (1) | SI4007777T1 (cg-RX-API-DMAC7.html) |
| SM (1) | SMT202400013T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021023721A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202201166B (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4475896A1 (en) * | 2022-02-09 | 2024-12-18 | Hadasit Medical Research Services&Development Ltd. | Anti-bcma car to target immune-related disorders, compositions and method thereof |
| EP4378953A1 (en) * | 2022-12-02 | 2024-06-05 | Universitat de Barcelona | Cd229 targeting moiety for the tratment of cd229 positive cancer |
| WO2025141187A1 (en) * | 2023-12-29 | 2025-07-03 | Fundación Para La Investigación Biomédica Del Hospital Universitario 12 De Octubre | T cells expressing anti-bcma/anti-cd3 bispecific antibodies and uses thereof |
| CN122140960B (zh) * | 2026-05-11 | 2026-08-11 | 重庆医科大学附属第一医院 | 一种双适配体修饰的膜融合脂质体及其制备方法与应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| DE68927933T2 (de) | 1988-09-02 | 1997-08-14 | Dyax Corp | Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ES2139598T3 (es) | 1990-07-10 | 2000-02-16 | Medical Res Council | Procedimientos para la produccion de miembros de parejas de union especifica. |
| DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
| DE69233697T2 (de) | 1991-03-01 | 2008-01-24 | Dyax Corp., Cambridge | Verfahren zur Entwicklung von bindenden Mikroproteinen |
| PT100379B (pt) | 1991-04-10 | 1999-01-29 | Scripps Research Inst | Bibliotecas de receptores heterodimericos usando fagomideos |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| AU6827094A (en) | 1993-05-07 | 1994-12-12 | Immunex Corporation | Cytokine designated 4-1bb ligand and human receptor that binds thereto |
| NO3051026T3 (cg-RX-API-DMAC7.html) | 2011-10-21 | 2018-07-28 | ||
| EP2914628A1 (en) * | 2012-11-01 | 2015-09-09 | Max-Delbrück-Centrum für Molekulare Medizin | An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases |
| ES2546743B1 (es) | 2014-03-28 | 2016-07-07 | Institut D'investigació Biomèdica De Bellvitge (Idibell) | Marcadores mitocondriales de enfermedades neurodegenerativas |
| BR112016024546A2 (pt) | 2014-04-30 | 2018-01-23 | Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft | anticorpo ou fragmento de anticorpo, anticorpo ou fragmento de anticorpo isolado, conjugado de anticorpo-fármaco, molécula de ácido nucleico, célula hospedeira, e, composição farmacêutica |
| KR20170066546A (ko) | 2014-10-03 | 2017-06-14 | 노파르티스 아게 | 조합 요법 |
| US12048718B2 (en) * | 2016-06-07 | 2024-07-30 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Geminschaft | Chimeric antigen receptor and CAR-T cells that bind BCMA |
| CN108004259B (zh) * | 2016-11-02 | 2020-06-30 | 上海恒润达生生物科技有限公司 | 靶向b细胞成熟抗原的嵌合抗原受体及其用途 |
| CN108285489A (zh) * | 2017-01-09 | 2018-07-17 | 上海恒润达生生物科技有限公司 | 靶向BCMA-BBz-tEGFR的嵌合抗原受体及其用途 |
| CN108395478A (zh) * | 2017-02-04 | 2018-08-14 | 上海恒润达生生物科技有限公司 | 靶向bcma的嵌合抗原受体并对其双重修饰的方法及其用途 |
| BR112019023608A2 (pt) * | 2017-05-12 | 2020-05-26 | Crispr Therapeutics Ag | Materiais e métodos para células manipuladas e seus usos em imuno-oncologia |
| AU2019233613B2 (en) | 2018-03-13 | 2025-02-13 | Sepsia Therapeutics, S.L. | Bacterial-binding peptides for treatment of infectious diseases and related inflammatory processes |
-
2020
- 2020-08-03 HU HUE20757544A patent/HUE064890T2/hu unknown
- 2020-08-03 AU AU2020325690A patent/AU2020325690A1/en active Pending
- 2020-08-03 EP EP23190869.0A patent/EP4272837A3/en active Pending
- 2020-08-03 HR HRP20240037TT patent/HRP20240037T1/hr unknown
- 2020-08-03 LT LTEPPCT/EP2020/071831T patent/LT4007777T/lt unknown
- 2020-08-03 CA CA3148930A patent/CA3148930A1/en active Pending
- 2020-08-03 EP EP20757544.0A patent/EP4007777B1/en active Active
- 2020-08-03 PL PL20757544.0T patent/PL4007777T3/pl unknown
- 2020-08-03 JP JP2022506455A patent/JP7729561B2/ja active Active
- 2020-08-03 PT PT207575440T patent/PT4007777T/pt unknown
- 2020-08-03 WO PCT/EP2020/071831 patent/WO2021023721A1/en not_active Ceased
- 2020-08-03 SM SM20240013T patent/SMT202400013T1/it unknown
- 2020-08-03 DK DK20757544.0T patent/DK4007777T5/da active
- 2020-08-03 SI SI202030350T patent/SI4007777T1/sl unknown
- 2020-08-03 RS RS20240043A patent/RS65094B1/sr unknown
- 2020-08-03 ES ES20757544T patent/ES2971033T3/es active Active
- 2020-08-03 FI FIEP20757544.0T patent/FI4007777T3/fi active
- 2020-08-03 US US17/632,191 patent/US12509525B2/en active Active
-
2022
- 2022-01-25 ZA ZA2022/01166A patent/ZA202201166B/en unknown